AXSM Axsome Therapeutics, Inc.

$208.47 -0.69%

Updated 17 d ago

Healthcare · Pharmaceutical Preparations

Axsome Therapeutics, Inc. (AXSM) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $10.9 billion. Shares last traded at $208.47, 19.2% below their 52-week high. Over the past year the stock is up 70.9%. Net profit margin is -24.7%, below the peer median of -8.9%. Revenue grew 65.5% year over year.

Market Cap

$10.9B

Shares Out

52.4M

EPS (TTM)

$-8.82

P/E Ratio

—

P/S Ratio

14.06

P/B Ratio

131.08

Dividend / Share

—

Dividend Yield

—

52-Week High

$257.94

52-Week Low

$112.79

Volume

51,946

Avg Vol (3m)

46,639.714

Performance

+1.11%

-2.06%

-9.87%

+29.16%

YTD

+16.67%

+70.88%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

44.98

SMA (50)

$224.37

SMA (200)

$194.42

Price vs SMA50

-7.09%

Price vs SMA200

+7.23%

ATR (14)

$7.82

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue

$777M

Net Income

$-192M

Gross Margin

—

Operating Margin

-24.0%

Net Margin

-24.7%

Return on Equity

-230.1%

Return on Assets

-25.2%

Current Ratio

1.43

Debt / Equity

1.42

Revenue Growth (YoY)

+65.5%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

Period	EPS (diluted)	Reported
Q2 2026	$-2.25	2026-08-10
Q1 2026	$-1.26	2026-05-04
FY 2025	$-3.68	2026-02-23
Q3 2025	$-3.13	2025-11-03
Q2 2026	$-2.18	2026-08-10
Q1 2026	$-1.22	2026-05-04

Full earnings history →

Pharmaceutical Preparations peers

AXSM vs 14 industry peers (Pharmaceutical Preparations), by market cap. Updated 17 d ago

P/S vs peers

14.06 / 11.11 med

+27% premium

Net margin vs peers

-24.7% / -8.9% med

below median

1–14 of 14


LLY	Lilly (Eli)	$1.09T	40.86	13.70	33.5%	-0.02%
JNJ	Johnson & Johnson	$670.6B	31.88	6.85	21.5%	+1.04%
ONC	Beone Medicines Ltd.	$535.9B	817.25	87.43	10.7%	+0.23%
ABBV	AbbVie	$459.8B	72.87	7.14	9.8%	-0.57%
MRK	Merck	$375.8B	118.44	5.65	4.8%	+0.44%
ABT	Abbott Laboratories	$189.5B	30.20	4.20	13.9%	-1.50%
PFE	Pfizer	$164.2B	37.91	2.58	6.8%	-0.76%
VRTX	Vertex Pharmaceuticals	$141.5B	32.11	11.24	35.0%	+0.24%
BMY	Bristol Myers Squibb	$139.1B	14.98	2.83	18.9%	+0.62%
REGN	Regeneron Pharmaceuticals	$87.2B	20.15	5.61	27.9%	-1.02%
TEVA	Teva Pharmaceutical Industries Ltd	$42.6B	60.41	2.46	4.1%	-2.32%
ALNY	Alnylam Pharmaceuticals	$35.4B	43.77	9.52	21.8%	-1.10%
ZTS	Zoetis	$31.5B	12.05	3.31	27.5%	+0.16%
RPRX	Royalty Pharma Plc	$28.2B	34.56	11.11	32.1%	+1.24%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.